Zyversa Therapeutics أخبار Eulerpool

Zyversa Therapeutics إيولربول AFX

أخبار سهم Zyversa Therapeutics

يتابع Zyversa Therapeutics العديد من الصحفيين والمستثمرين حول العالم. نقدم هنا أحدث أخبار Zyversa Therapeutics.

• ٣ سبتمبر ·

  Seeking Alpha
  ZyVersa Therapeutics files for mixed shelf offering
• ٣ سبتمبر ·

  Thefly.com
  ZyVersa Therapeutics files $100M mixed securities shelf
• ٩ أغسطس ·

  Yahoo
  ZyVersa Therapeutics Reports Second Quarter, 2024 Financial Results and Provides Business Update
• ٩ أغسطس ·

  InvestorPlace
  ZVSA Stock Earnings: ZyVersa Therapeutics Beats EPS for Q2 2024
• ٩ أغسطس ·

  Seeking Alpha
  ZyVersa Therapeutics GAAP EPS of -$3.31 beats by $0.44
• ٧ أغسطس ·

  Yahoo
  ZyVersa Therapeutics Announces Published Data Supporting the Rationale for Inhibiting Inflammasome ASC with IC 100 to Control Chronic Inflammation
• ٧ أغسطس ·

  Thefly.com
  ZyVersa Therapeutics announces publication of data on extracellular ASC
• ٢٩ يوليو ·

  Yahoo
  ZyVersa Therapeutics Announces Published Data Demonstrating That Plasma Levels of Inflammasome ASC Show Promise as Biomarker of Early Cognitive Changes in Older Adults
• ٢٩ يوليو ·

  Thefly.com
  ZyVersa Therapeutics announces publication of data on inflammasome ASC
• ٢٥ يوليو ·

  Yahoo
  ZyVersa Therapeutics Selects Obesity and Related Metabolic Complications as Lead Indication for Inflammasome ASC Inhibitor IC 100